PUBLISHER: The Business Research Company | PRODUCT CODE: 1948355
PUBLISHER: The Business Research Company | PRODUCT CODE: 1948355
Transcatheter Embolization and Occlusion Devices are medical instruments employed in minimally invasive procedures to halt blood flow in specific regions of the body. These devices are introduced via a catheter, a slender, flexible tube inserted into the vascular system. The primary objective of these interventions is to address various medical conditions by obstructing blood supply to particular tissues or organs.
The principal types of transcatheter embolization and occlusion devices include coil and non-coil variants. Coil devices are small, wire-like structures utilized in transcatheter embolization procedures to obstruct blood flow to targeted areas, often employed in the treatment of aneurysms or to impede blood flow to tumors. They find applications across domains such as peripheral vascular disease, oncology, neurology, urology, among others, and are utilized by end-users including hospitals, ambulatory surgical centers, clinics, and others.
Tariffs are impacting the transcatheter embolization and occlusion devices market by increasing costs of imported specialty polymers, metal alloys, microcatheters, imaging-compatible components, and precision manufacturing equipment. Hospitals and interventional centers in North America and Europe are most affected due to reliance on imported high-performance medical materials, while Asia-Pacific faces cost pressure on device exports. These tariffs are raising procedure costs and affecting procurement budgets. However, they are also encouraging localized device manufacturing, regional material sourcing, and innovation in cost-effective embolization and occlusion technologies.
The transcatheter embolization and occlusion devices market research report is one of a series of new reports from The Business Research Company that provides transcatheter embolization and occlusion devices market statistics, including transcatheter embolization and occlusion devices industry global market size, regional shares, competitors with a transcatheter embolization and occlusion devices market share, detailed transcatheter embolization and occlusion devices market segments, market trends and opportunities, and any further data you may need to thrive in the transcatheter embolization and occlusion devices industry. This transcatheter embolization and occlusion devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The transcatheter embolization and occlusion devices market size has grown rapidly in recent years. It will grow from $5.23 billion in 2025 to $5.79 billion in 2026 at a compound annual growth rate (CAGR) of 10.6%. The growth in the historic period can be attributed to expansion of interventional radiology procedures, rising prevalence of vascular disorders, increased availability of catheter-based therapies, growing adoption of minimally invasive treatments, improvements in imaging-guided intervention techniques.
The transcatheter embolization and occlusion devices market size is expected to see strong growth in the next few years. It will grow to $8.33 billion in 2030 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to increasing demand for targeted embolization therapies, rising adoption of advanced embolic materials, expansion of oncology and neurointerventional procedures, growing focus on precision medicine, increasing investments in interventional healthcare infrastructure. Major trends in the forecast period include increasing adoption of minimally invasive embolization procedures, rising demand for advanced liquid embolic agents, growing use of detachable and coated coils, expansion of image-guided interventional techniques, enhanced focus on precision occlusion technologies.
The growing demand for minimally invasive surgical techniques is expected to propel the growth of the transcatheter embolization and occlusion devices market going forward. Minimally invasive surgeries use small incisions or robotic-assisted tools to access internal structures, minimizing tissue damage and resulting in reduced trauma, shorter recovery times, less postoperative pain, and a lower risk of complications. The rising preference for these procedures is driven by advancements in surgical technology, increased patient awareness of less-invasive options, and improved clinical outcomes. Transcatheter embolization and occlusion devices facilitate such minimally invasive interventions by enabling targeted, catheter-based treatments with high precision and minimal disruption to surrounding tissues. For instance, in January 2025, according to Intuitive Surgical, Inc., a US-based medical technology company, worldwide da Vinci procedures in 2024 increased by approximately 17% compared with 2023, and are expected to grow by 13% to 16% in 2025. Therefore, the increasing adoption of minimally invasive techniques is driving the growth of the transcatheter embolization and occlusion devices market.
Major companies operating in the transcatheter embolization and occlusion devices market are focusing on developing advanced solutions, such as liquid embolic systems, to address the growing demand for minimally invasive vascular interventions and precise management of arterial hemorrhage. A liquid embolic system is a non-adhesive, polymer-based embolization technology delivered through a microcatheter that solidifies upon contact with blood, enabling controlled occlusion of abnormal or damaged vessels while offering deeper penetration and greater accuracy than conventional coil-based methods. For instance, in July 2025, Medtronic plc., a US-based medical technology company, initiated clinical evaluation of its Onyx Liquid Embolic System (LES) through an IDE study for embolization of arterial hemorrhage in the peripheral vasculature. The system uses an ethylene-vinyl alcohol (EVOH) copolymer dissolved in DMSO and combined with tantalum powder for radiopacity, allowing physicians to visualize and precisely control delivery in real time. Upon solvent diffusion, it forms a cohesive embolus that achieves targeted vessel occlusion with reduced risk of catheter entrapment. Designed for active peripheral arterial bleeding, this system enhances precision, supports minimally invasive workflows, and broadens therapeutic options for interventional specialists.
In February 2025, Stryker Corporation, a US-based healthcare technology company, acquired Inari Medical Inc. for an undisclosed amount. Through this acquisition, Stryker aimed to expand its footprint in the rapidly growing peripheral vascular intervention market and enhance its portfolio with advanced venous thrombectomy technologies. Inari Medical Inc. is a US-based medical device company specializing in minimally invasive mechanical thrombectomy systems and the development of transcatheter mechanical thrombectomy devices.
Major companies operating in the transcatheter embolization and occlusion devices market are Johnson & Johnson Services Inc., Abbott Laboratories, Medtronic Inc., Stryker Corporation, Boston Scientific Corporation, Terumo Corporation, Teleflex Incorporated, Cook Medical, Merit Medical Systems Inc., Penumbra Inc., Sirtex Medical Limited, Cordis Corporation, pfm medical ag, Micro Interventional Devices Inc., Acandis GmbH, Metactive Medical Inc., Balt Group, Kaneka Medix Corporation, Shape Memory Medical Inc., Boston Scientific Neurovascular
North America was the largest region in the transcatheter embolization and occlusion devices market in 2025. The regions covered in the transcatheter embolization and occlusion devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the transcatheter embolization and occlusion devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The transcatheter embolization and occlusion devices market consists of sales of microspheres, gelatin sponges, and coil-assisted detachable balloons. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Transcatheter Embolization And Occlusion Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses transcatheter embolization and occlusion devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for transcatheter embolization and occlusion devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The transcatheter embolization and occlusion devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.